245 articles in this topic
New analysis reveals that comparing weight changes between diabetes medications requires more sophisticated research methods.
Study of 123 teens shows preoperative weight fluctuations have minimal impact on surgical outcomes years later.
Major study finds 43% of obesity medications prescribed to teens go unfilled, with Hispanic youth facing greatest barriers to access.
Weekly tirzepatide injections led to up to 22% weight loss in Japanese participants, with 96-100% achieving clinically significant results.
International study shows surgical treatment significantly reduces cardiovascular risks compared to medication alone.
New research reveals why Addison's disease patients face higher mortality despite treatment and explores promising therapeutic approaches.
Inclisiran safely reduced LDL cholesterol by 28% in adolescents with familial hypercholesterolemia, offering hope for early intervention.
New research examines whether the cholesterol-lowering drug inclisiran could benefit pediatric patients with genetic high cholesterol.
35-year study reveals people with high genetic diabetes risk face dramatically increasing disease rates in modern environments.
Comprehensive review reveals estrogen-only therapy carries lower breast cancer risk than combined hormone treatments during menopause.
Three-month romosozumab protocol offers pragmatic solution for osteoporosis treatment with potentially improved patient outcomes.
Three months of romosozumab plus denosumab matched 12 months of romosozumab alone for bone strength gains in postmenopausal women.
